Literature DB >> 7632985

Light treatment for sleep disorders: consensus report. II. Basic properties of circadian physiology and sleep regulation.

D J Dijk1, Z Boulos, C I Eastman, A J Lewy, S S Campbell, M Terman.   

Abstract

The rationale for the treatment of sleep disorders by scheduled exposure to bright light in seasonal affective disorder, jet lag, shift work, delayed sleep phase syndrome, and the elderly is, in part, based on a conceptual framework developed by nonclinical circadian rhythm researchers working with humans and other species. Some of the behavioral and physiological data that contributed to these concepts are reviewed, and some pitfalls related to their application to bright light treatment of sleep disorders are discussed. In humans and other mammals the daily light-dark (LD) cycle is a major synchronizer responsible for entrainment of circadian rhythms to the 24-h day, and phase response curves (PRCs) to light have been obtained. In humans, phase delays can be induced by light exposure scheduled before the minimum of the endogenous circadian rhythm of core body temperature (CBT), whereas phase advances are induced when light exposure is scheduled after the minimum of CBT. Since in healthy young subjects the minimum of CBT is located approximately 1 to 2 h before the habitual time of awakening, the most sensitive phase of the PRC to light coincides with sleep, and the timing of the monophasic sleep-wake cycle itself is a major determinant of light input to the pacemaker. The effects of light are mediated by the retinohypothalamic tract, and excitatory amino acids play a key role in the transduction of light information to the suprachiasmatic nuclei. LD cycles have direct "masking" effects on many variables, including sleep, which complicates the assessment of endogenous circadian phase and the interpretation of the effects of light treatment on sleep disorders. In some rodents motor activity has been shown to affect circadian phase, but in humans the evidence for such a feedback of activity on the pacemaker is still preliminary. The endogenous circadian pacemaker is a major determinant of sleep propensity and sleep structure; these, however, are also strongly influenced by the prior history of sleep and wakefulness. In healthy young subjects, light exposure schedules that do not curtail sleep but induce moderate shifts of endogenous circadian phase have been shown to influence the timing of sleep and wakefulness without markedly affecting sleep structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632985     DOI: 10.1177/074873049501000204

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  10 in total

Review 1.  Circadian rhythm and cardiovascular disease.

Authors:  Elizabeth Shaw; Geoffrey H Tofler
Journal:  Curr Atheroscler Rep       Date:  2009-07       Impact factor: 5.113

2.  Repetitive transcranial magnetic stimulation activates specific regions in rat brain.

Authors:  R R Ji; T E Schlaepfer; C D Aizenman; C M Epstein; D Qiu; J C Huang; F Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  The relationship between fatigue and light exposure during chemotherapy.

Authors:  Lianqi Liu; Matthew R Marler; Barbara A Parker; Vicky Jones; Sherella Johnson; Mairav Cohen-Zion; Lavinia Fiorentino; Georgia Robins Sadler; Sonia Ancoli-Israel
Journal:  Support Care Cancer       Date:  2005-04-29       Impact factor: 3.603

5.  Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep.

Authors:  Horng-Shiuann Wu; F Gao; L Yan; C Given
Journal:  Chronobiol Int       Date:  2021-11-03       Impact factor: 2.877

Review 6.  Disorders of the sleep-wake cycle in adults.

Authors:  P M Sedgwick
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

7.  Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy.

Authors:  Neelum Jeste; Lianqi Liu; Michelle Rissling; Vera Trofimenko; Loki Natarajan; Barbara A Parker; Sonia Ancoli-Israel
Journal:  Qual Life Res       Date:  2012-08-03       Impact factor: 4.147

8.  Bright light shows promise in improving sleep, depression, and quality of life in women with breast cancer during chemotherapy: findings of a pilot study.

Authors:  Horng-Shiuann Wu; J E Davis; L Chen
Journal:  Chronobiol Int       Date:  2021-01-21       Impact factor: 2.877

9.  Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis.

Authors:  Chun-Hung Chang; Chieh-Yu Liu; Shaw-Ji Chen; Hsin-Chi Tsai
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-14       Impact factor: 2.570

10.  Ethnicity, sleep, mood, and illumination in postmenopausal women.

Authors:  Daniel F Kripke; Girardin Jean-Louis; Jeffrey A Elliott; Melville R Klauber; Katharine M Rex; Arja Tuunainen; Robert D Langer
Journal:  BMC Psychiatry       Date:  2004-04-07       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.